Jci_page_head_homepage_01 Jci_page_head_homepage_02
Stephan Grabbe, Georg Varga, Stefan Beissert, Meike Steinert, Gunther Pendl, Stephan Seeliger, Wilhelm Bloch, Thorsten Peters, Thomas Schwarz, Cord Sunderkötter, Karin Scharffetter-Kochanek
Published in Volume 109, Issue 2
J Clin Invest. 2002; 109(2):183–192 doi:10.1172/JCI11703
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 8

Accumulation of 51Cr-labeled T cells and DCs at skin sites of ACD. Mice were sensitized and challenged with the hapten OXA. T cells and DCs were generated as described in Methods, labeled with 51Cr, and injected intravenously 24 hours after hapten challenge. Six hours later, ears and internal organs were harvested and 51Cr was counted. Data represent percentage of incorporated 51Cr in the ear in relation to the combined radioactivity uptake in lungs, liver, and spleen. *P < 0.01 for WT versus CD18–/– T cells; P = not significant for all other groups.